FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977243376> ?p ?o ?g. }

• W1977243376 endingPage "2011" @default.
• W1977243376 startingPage "2003" @default.
• W1977243376 abstract "The effects of 3'-azido-3'-deoxythymidine (AZT), phosphonoformate (PFA), and 2',3'-dideoxythymidine (ddT) and their combination on human immunodeficiency type 1 (HIV-1) replication were studied by measuring the HIV-1 p24 antigen expression and reverse transcriptase (RT) release in HIV-1-infected MT4 cells in vitro. RT activity was also measured in a cell-free system by using poly(rA)-oligo(dT) as the primer-template, and cell growth inhibition was measured in noninfected MT4 cells. The interactions of these two- and three-drug combinations were evaluated by the combination index (CI) method and isobologram techniques. The 50% effective concentrations (EC50s) of AZT, PFA, and ddT were 0.014 to 0.005, 9.4 to 8.8, and 8.4 to 2.5 microM, respectively, for p24 enzyme-linked immunosorbent assays (ELISAs) and 0.005 to 0.0034, 1.43 to 1.37, and 2.87 to 2.83 microM, respectively, for RT activity in vitro; for RT activity in the cell-free system, the EC50s were 0.00019 to 0.00024, 0.012 to 0.02, and 0.00074 to 0.0005 microM, for AZT-5'-triphosphate, PFA, and ddT-5'-triphosphate, respectively. AZT in combination with PFA (1:200) or ddT (1:5) as well as the combination of these three drugs (1:200:5) synergistically inhibited HIV-1 replication and RT activity in the cell-free system over a wide range of drug concentrations, with the CIs ranging from 0.5 to 0.09, in which CIs of less than 1, 1, and greater than 1 indicate synergism, additive effect, and antagonism, respectively. Three- and two-drug combinations of AZT, PFA, and ddT showed similar degrees of synergism against HIV-1 replication in p24 assays and RT release assays, whereas the combination of AZT and ddT was found to be the most selective in terms of its anti-HIV-1 effect versus cytotoxicity. Dose reduction indices calculated from both HIV-1 replication inhibition, as measured by p24 ELISA and by RT activity in the cell-free system, indicated that two- and three-drug combinations at high effect levels and the selected combination ratios allow 2- to 240-fold dose reduction over the single drug alone in terms of their anti-HIV-1 effects. The three-drug combination showed the highest dose reduction index. These finding suggest that increased efficacy and reduced toxicity may be achieved in AIDS therapy by using AZT, PFA, and ddT in two- or three-drug combinations." @default.
• W1977243376 created "2016-06-24" @default.
• W1977243376 creator A5026225196 @default.
• W1977243376 creator A5027078344 @default.
• W1977243376 creator A5038176351 @default.
• W1977243376 creator A5048398642 @default.
• W1977243376 creator A5052464965 @default.
• W1977243376 creator A5072929702 @default.
• W1977243376 creator A5077370799 @default.
• W1977243376 creator A5080362408 @default.
• W1977243376 creator A5089554969 @default.
• W1977243376 date "1991-10-01" @default.
• W1977243376 modified "2023-10-18" @default.
• W1977243376 title "Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine" @default.
• W1977243376 cites W1591106880 @default.
• W1977243376 cites W1966668708 @default.
• W1977243376 cites W1977282539 @default.
• W1977243376 cites W1995689745 @default.
• W1977243376 cites W1996177037 @default.
• W1977243376 cites W1996835323 @default.
• W1977243376 cites W1997685222 @default.
• W1977243376 cites W2006477218 @default.
• W1977243376 cites W2010363116 @default.
• W1977243376 cites W2014175575 @default.
• W1977243376 cites W2028541088 @default.
• W1977243376 cites W2057377429 @default.
• W1977243376 cites W2065235873 @default.
• W1977243376 cites W2077945404 @default.
• W1977243376 cites W2085459671 @default.
• W1977243376 cites W2086186867 @default.
• W1977243376 cites W2100482792 @default.
• W1977243376 cites W2113223804 @default.
• W1977243376 cites W2131575544 @default.
• W1977243376 cites W2143811153 @default.
• W1977243376 cites W2149364672 @default.
• W1977243376 cites W2164935821 @default.
• W1977243376 cites W2413729856 @default.
• W1977243376 cites W264716909 @default.
• W1977243376 doi "https://doi.org/10.1128/aac.35.10.2003" @default.
• W1977243376 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/245315" @default.
• W1977243376 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1722077" @default.
• W1977243376 hasPublicationYear "1991" @default.
• W1977243376 type Work @default.
• W1977243376 sameAs 1977243376 @default.
• W1977243376 citedByCount "41" @default.
• W1977243376 countsByYear W19772433762013 @default.
• W1977243376 countsByYear W19772433762014 @default.
• W1977243376 countsByYear W19772433762016 @default.
• W1977243376 countsByYear W19772433762017 @default.
• W1977243376 countsByYear W19772433762022 @default.
• W1977243376 crossrefType "journal-article" @default.
• W1977243376 hasAuthorship W1977243376A5026225196 @default.
• W1977243376 hasAuthorship W1977243376A5027078344 @default.
• W1977243376 hasAuthorship W1977243376A5038176351 @default.
• W1977243376 hasAuthorship W1977243376A5048398642 @default.
• W1977243376 hasAuthorship W1977243376A5052464965 @default.
• W1977243376 hasAuthorship W1977243376A5072929702 @default.
• W1977243376 hasAuthorship W1977243376A5077370799 @default.
• W1977243376 hasAuthorship W1977243376A5080362408 @default.
• W1977243376 hasAuthorship W1977243376A5089554969 @default.
• W1977243376 hasBestOaLocation W19772433761 @default.
• W1977243376 hasConcept C104317684 @default.
• W1977243376 hasConcept C140704245 @default.
• W1977243376 hasConcept C153911025 @default.
• W1977243376 hasConcept C156719811 @default.
• W1977243376 hasConcept C159047783 @default.
• W1977243376 hasConcept C185592680 @default.
• W1977243376 hasConcept C202751555 @default.
• W1977243376 hasConcept C2522874641 @default.
• W1977243376 hasConcept C2780216070 @default.
• W1977243376 hasConcept C2780727368 @default.
• W1977243376 hasConcept C3013748606 @default.
• W1977243376 hasConcept C54355233 @default.
• W1977243376 hasConcept C55493867 @default.
• W1977243376 hasConcept C67705224 @default.
• W1977243376 hasConcept C81885089 @default.
• W1977243376 hasConcept C86803240 @default.
• W1977243376 hasConcept C98274493 @default.
• W1977243376 hasConceptScore W1977243376C104317684 @default.
• W1977243376 hasConceptScore W1977243376C140704245 @default.
• W1977243376 hasConceptScore W1977243376C153911025 @default.
• W1977243376 hasConceptScore W1977243376C156719811 @default.
• W1977243376 hasConceptScore W1977243376C159047783 @default.
• W1977243376 hasConceptScore W1977243376C185592680 @default.
• W1977243376 hasConceptScore W1977243376C202751555 @default.
• W1977243376 hasConceptScore W1977243376C2522874641 @default.
• W1977243376 hasConceptScore W1977243376C2780216070 @default.
• W1977243376 hasConceptScore W1977243376C2780727368 @default.
• W1977243376 hasConceptScore W1977243376C3013748606 @default.
• W1977243376 hasConceptScore W1977243376C54355233 @default.
• W1977243376 hasConceptScore W1977243376C55493867 @default.
• W1977243376 hasConceptScore W1977243376C67705224 @default.
• W1977243376 hasConceptScore W1977243376C81885089 @default.
• W1977243376 hasConceptScore W1977243376C86803240 @default.
• W1977243376 hasConceptScore W1977243376C98274493 @default.
• W1977243376 hasIssue "10" @default.
• W1977243376 hasLocation W19772433761 @default.
• W1977243376 hasLocation W19772433762 @default.

• next